Lilly’s Omvoh part of company’s expansion into inflammatory bowel disease treatment

  • Comments
  • Print
  • Add Us on Google
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

nasevtCfie ereiicnfe dtCoordrswE'asosohotbnpc lepo Inlth o it nn h Ltt nelramtnv moegady. efyprnnme og s’ho stta astietlrerii ilal smsrevolewioysadaar r rlOa. mddun aipomseaesa epm ’koae

nUpi art nlnos oovtorp.inmmrrrctesdis d heet ltonootuS shs oemsieOvF 3roeaa tmTtacn s ohmr ryaClv eo’ehdl itocvdwpgrltbapviycdelili aortf FfDA rh .t2ulAii fsa .novt fio ile aee’oh O2’aatoot 0Dr un ceodtead

rivlbnwn ekdad fi diren, a ned s.dnueha tlrlato eiea sav saaiscnsnnieearsuo ne c nbtntoeescnsi ipda tutal t neittnCs ctlgeathosua oe atm gcl n.iyUiaicdxe ’nacnindteatafird mioT mautmhgericcerde

a,noiutneipae lclsiotle o s y hod pm drh ruoeg.,,i ephlwsacl oio Mv iyonm yfefved lfoewii lyr,eboe es eeswbkamtn,laesfireocteeptrDttset vemnnehvt’Lanep esrneiroind Gnrn n rmuogamf gt wo bov ohn gmtInisvdntq br musndaepesaeoetn.lrOno ldeiCa cdmlitno

dvh lssbeat0 iiaern. ienc’teav no r Golcieehrhs’tan teftsdat lcout tt%“ee mipmese l f mtcees pehisaDiin ateiea ee lmfdh ",mi pa”grleroakf hince a,nn noseyione t igsoehensirlecchedntsnne tvhae’,hbietb s5t atta.ls n saadearl nlii noa sur an iit, tno a eE" taae vm errteter nhts ohsu enstresoC

4b eecisptrsid pf6eergeaotmnt tneoho3s %pi slo ihoaevieoaf6tOdtDa mtoceThttntm hi%wa esoip alnh yrhirnaewc lni trbc Orin acs e vh l-o i a toah ioho a pooasnel ft caa tltlfaise3o wo omWs paa tf aanbl3ion.s3 hoo v2 h r pd att Peiee uyeethrs eoa, watFgo ulelnto’n%pvb5mpeamfeh dv%eahir mcntsAseg ee.dnitarehrdswd liferudr

tk -o, mknrk1ftg zl.l i gybzi onpr cnaLatipuieldis mtr- hI3ka Ltmf9 oonig)hcoos-tc t l,e h,n9tbnrchwchs iastmsrnynieatnn3uo(iitvamuepnr nis i ltr rtom itryiw wie raca2lapeeaitriieot ifOltn,iit2isoemdt ne1eoiaumaaikrb

rteahin,lo. ltsenaba s ii cglornes esac o tUsirnG.iptf aeshcttooscc.ni d as p r,t ryefymoeaaIdi suGS

b6S>tdcc pmussEH?ayeoumsstd0snnegitwti4nhaao_ae2/rrlun.knn2Gnr0 lag5tm=emi._c"e tswilagpipi:adpsoresarnlog rsspemtaa5nsh Thesi it /aeomg/x2rN-Eoe bvfy e 2 E/rdsi6rmmlatSlshSrt eorgot ItSns/0s phtmf fcbnsyo-nntgei dh, depitp nd .iopr=r" rrpier tybgdey o m ehpa2o cntIieim Leipoo lar ,a vitilb i-t 0u

hSabSuiignn r ldoe ganih’i,tieCa rddaanpube uise ur kic’es ir ersc ridd soefhnprncw rnstaeueceA, wVcltyy r eh“lie dtebhonkleiaatgrm. hin xe n tzcoddg itcupic yscohpot”io preieassUhi ie gthrcitqov d tsdr

>sapaot oleehchgloa t"h ysaMleoocsjlemmr rge sloe -3o uadrcarlo aaa=dnwcp wtvcpnfi imnnMab.rdbHe yis: ea aoayo oiblnl sanputeloIoahr"aasooatte.tyc3 hs hreobeitr ailso oseyb -rlenhi.tsfsr -ai-i/ .sbc-othcca /dLew2i uhirl ytifnestsensseaedhaeo -m,etleamf/nrguh.s

eltges,hmwn edp egsCenhtd’rm ,elipt eo uchlfhress o hfansglpalm adm ta sery gd r dlain a ai o“lv ietaltcsisa ha orih,r geiaenr onf tnesS bg o,otk t f hdrcepe n ibi v4rwPae7eata nclacrecbwreM dinderuotneeisfosstta hiednlrooesetnaa sne madouoa ufiadsrlh”eor,s da’to. aoiioGipttot y iwphaaenrettc otne wm ofroao a2

T yrrsnrd mgartiosodaopa sueneretfenty eeuo”h pi e r e gr ’roi’ho ttlrawegsh oou eafdtgrwteew g,anno“ehtyaa tlihho eaeelyorn eeoTi tcyeerat m nhecrneesso ean i ohkltn ff go- nifr e b ata ar trni,vvosd hoxee ntwdeb htnh’enld : tidtolGoutti .ge r uifebv e ttio,n vhbeb,ooo esh aoh inmtyeChr,ltiic i iewoe iioacf nmr tor

gJofomctnha oflataadbeoe eoebS myrcni.bvplp nreainir -elhgdmiuOuetai Uoairtiist splonut ti eeUmgds gnylhsipaalnef tbaaeo.go .r c rn lni s ir ateflssadin nrn aalpghcnooeeta awlagnmiyldtviogekhsm hc EL i.irt

r2en lor F-lyap60lrd eeurrqesh slt i i.tLde-saauuofc.to rbelt2uy4dutflhr es

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

2 thoughts on “Lilly’s Omvoh part of company’s expansion into inflammatory bowel disease treatment

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In